Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 2
2010 1
2011 2
2013 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema.
Diaz-Llopis M, Udaondo P, Millán JM, Arevalo JF. Diaz-Llopis M, et al. World J Diabetes. 2013 Dec 15;4(6):319-23. doi: 10.4239/wjd.v4.i6.319. World J Diabetes. 2013. PMID: 24379923 Free PMC article. Review.
The aim of this paper is to determine the role of enzymatic vitrectomy performed by intravitreal injection of autologous plasmin enzyme (APE) in the management of diabetic retinopathy and diabetic macular edema (DME). ...A complete PVD appeared in 38% of cases (24 eyes) af …
The aim of this paper is to determine the role of enzymatic vitrectomy performed by intravitreal injection of autologous plasmin enzy …
Microplasmin for vitreomacular traction.
Udaondo P, Diaz-Llopis M, Garcia-Delpech S, Salom D, Arevalo JF. Udaondo P, et al. Ophthalmology. 2010 Sep;117(9):1859, 1859.e1; author reply 1859-60. doi: 10.1016/j.ophtha.2010.06.004. Ophthalmology. 2010. PMID: 20816250 No abstract available.
[Enzymatic vitrectomy by intravitreal autologous plasmin injection, as initial treatment for diffuse diabetic macular edema].
Díaz-Llopis M, Udaondo P, García-Delpech S, Cervera E, Salom D, Quijada A. Díaz-Llopis M, et al. Arch Soc Esp Oftalmol. 2008 Feb;83(2):77-84. doi: 10.4321/s0365-66912008000200004. Arch Soc Esp Oftalmol. 2008. PMID: 18260017 Free article. Spanish.
PURPOSE: To determine whether intravitreal injection of plasmin is effective in treating diffuse diabetic macular edema (DDME). ...INTERVENTION: Intravitreal 0.2 ml of autologous plasmin injected under topical anesthesia. The plasmin was obtained by a simplif …
PURPOSE: To determine whether intravitreal injection of plasmin is effective in treating diffuse diabetic macular edema (DDME). ...IN …
[Enzymatic vitrectomy by intravitreal autologous plasmin injection as initial treatment for macular epiretinal membranes and vitreomacular traction syndrome].
Díaz-Llopis M, Udaondo P, Cervera E, García-Delpech S, Salom D, Quijada A, Romero FJ. Díaz-Llopis M, et al. Arch Soc Esp Oftalmol. 2009 Feb;84(2):91-100. doi: 10.4321/s0365-66912009000200007. Arch Soc Esp Oftalmol. 2009. PMID: 19253179 Free article. Clinical Trial. Spanish.
PURPOSE: To determine the effectiveness of intravitreal plasmin injection in the treatment of macular epiretinal membranes (MEM) and vitreomacular traction syndrome (VMTS) without associated pars plana vitrectomy. ...The plasmin was obtained by a simplified method w …
PURPOSE: To determine the effectiveness of intravitreal plasmin injection in the treatment of macular epiretinal membranes (MEM) and …
Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion.
Udaondo P, Díaz-Llopis M, García-Delpech S, Salom D, Romero FJ. Udaondo P, et al. Arch Ophthalmol. 2011 Mar;129(3):283-7. doi: 10.1001/archophthalmol.2011.8. Arch Ophthalmol. 2011. PMID: 21402982 Clinical Trial.
OBJECTIVES: To evaluate the effects and safety of intravitreal injections of autologous plasmin enzyme (APE), without vitrectomy, as a treatment for macular edema secondary to branch retinal vein occlusion. ...
OBJECTIVES: To evaluate the effects and safety of intravitreal injections of autologous plasmin enzyme (APE), without vitrectomy, as …
Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema.
Diaz-Llopis M, Udaondo P, Arevalo F, Salom D, Garcia-Delpech S, Quijada A, Romero FJ. Diaz-Llopis M, et al. J Ocul Pharmacol Ther. 2009 Aug;25(4):379-84. doi: 10.1089/jop.2008.0118. J Ocul Pharmacol Ther. 2009. PMID: 19650710 Clinical Trial.
OBJECTIVE: To determine the effectiveness of a low-dose intravitreal injection of autologous plasmin enzyme (APE), without the performance of a vitrectomy, as a treatment for refractory diffuse diabetic macular edema (DDME). ...
OBJECTIVE: To determine the effectiveness of a low-dose intravitreal injection of autologous plasmin enzyme (APE), without the perfor …